Financial News
Update: Stonegate Initiates Coverage on Sirona Biochem Corp (TSX-V:SBM)
October 21, 2024 at 14:00 PM EDT
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.
DALLAS - 
(NewMediaWire) - October 21, 2024 - Sirona Biochem Corp: Stonegate Capital Partners initiates their coverage on Sirona Biochem Corp (TSX-V:SBM) (FSE: ZSB) (OTC: SRBCF).
To view the full announcement, including downloadable images, bios, and more, click here.
Key Takeaways:
- GlycoProteMim™ is a potential standout in the premium skincare market
- Sirona is targeting profitability by 2025, with expected revenue from Allergan Aesthetic and the commercialization of GlycoProteMim™ set to drive growth.
- Sirona’s partnerships place it in a strong position to capture market share in the growing global skincare industry.
Click image above to view full announcement.
About Stonegate
Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking services for public and private companies.
Contacts:
Stonegate Capital Partners
(214) 987-4121
info@stonegateinc.com
Source: Stonegate, Inc.
Report this content
If you believe this article contains misleading, harmful, or spam content, please let us know.
Report this article
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
